 Breakthrough data on the successful encapsulation of a biologic using Q-Sphera technology Significant progress across multiple other RD programmes ABINGDON, OXFORDSHIRE ACCESSWIRE June 17, 2021 Midatech Pharma PLC AIM:MTPH.LNASDAQ:MTP, an RD biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces breakthrough in vitro data which demonstrate Q-Spheras potential to formulate proteins into long-acting injectable products, as well as significant progress across multiple other programmes. In the 13 months since the announcement of a Strategic Review, the Company has shut down its Bilbao operations, thereby halving its monthly cash burn rate and pivoted from a largely singular focus on one Phase III ready asset MTD201, Q-Sphera octreotide to multiple shots on goal with an expanded pipeline of nine earlier stage programmes. 